COVAXIN shows interim efficacy of 81% against coronavirus in Phase 3 clinical trials, says Bharat Biotech in Firstpost Tech Latest News Gadgets News Latest Gadgets Technology News published on March 03, 2021 leave a reply via Firstpost Tech Latest News https://ift.tt/2MGpWD9 Tweet Share Share Share Share Previous Post Next Post post written by: Ashok.HindiGadgets360
0 comments: